Drug Profile
T 3262P
Latest Information Update: 29 Oct 2018
Price :
$50
*
At a glance
- Originator Showa Yakuhin Kako; Toyama Chemical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Periodontal disorders
Most Recent Events
- 07 Jan 2002 New profile
- 07 Jan 2002 Investigation in Periodontal disorders in Japan (Topical)